MedTrace Logo

Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood

NCT00064597 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2005-06-24

No results posted yet for this study

Summary

This purpose of this study is to develop noninvasive methods of prenatal diagnosis. Fetal cells can be found in maternal blood. This study is designed to isolate these fetal cells from a sample of the pregnant woman's blood and use those cells to test for fetal chromosome abnormalities.

Conditions

  • Chromosome Disorders

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    lead NIH

Principal Investigators

  • Laird Jackson, MD

  • Diana Bianchi, MD

  • Mark Evans, MD

  • Sherman Elias, MD

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1987-12-31
Completion
2003-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00064597 on ClinicalTrials.gov